For a number of individuals claiming to have suffered debilitating pain as a result of defective hip implants manufactured and sold by Biomet, Inc., their cases may soon come to an end – in their favor.  According to allegations made in the lawsuits, including those brought by Sommers Schwartz, these defective medical devices use a metal-on-metal design that has been shown to generate high levels of metal ions that then infiltrate and infect surrounding tissue (known as metallosis), and have a higher than normal overall failure rate.

On February 3, 2014, Biomet and attorneys representing the many plaintiffs in these suits agreed to a settlement, which federal Judge Robert Miller, Jr. of the U.S District Court for the Northern District of Indiana – assigned to oversee the coordinated multidistrict cases – subsequently approved.  Pursuant to the terms of the settlement, individuals who underwent revision surgeries after suffering metal-on-metal related failures of Biomet Magnum hip implant devices will receive a base award of $200,000, provided that the failure was not the result of infection, trauma, or other injury unrelated to the metal-on-metal design.  Award amounts will be discounted according the number of years between the implant and revision procedures, but no adjustments will be made relative to age, obesity, or smoking.  Cases in which plaintiffs underwent revision surgery for double hip implants are being addressed independently of the base award provision.

The settlement is not comprehensive.  Cases in which plaintiffs did not undergo revision procedures are not part of the agreement and will now be litigated under a separate docket. has already been created for filed non-revision cases. Nor are non-revision cases part of the settlement.

In product liability and defective medical device matters, injured individuals have a certain amount of time in which to file their claims, known as a statute of limitations.  Under the Master Settlement Agreement, Biomet has agreed to a provision that would allow the statute of limitations to commence on the date the individual undergoes revision surgery, affording a potentially larger window in which plaintiffs may file suit to recover damages for their injuries.  In situations where the statute of limitations has expired based upon the date of the revision procedure, those cases are deemed to have a presumed value of $20,000.

Other situations in which the presumptive $20,000 settlement would apply include:

  • Revisions of Biomet M2a devices other than the 38 and Magnum products
  • Biomet devices that failed within 6 months after implant
  • Devices that were revised more than 10 years after the date of implant
  • M2a devices including 38 and Magnum that were initially implanted during a revision surgery
  • Cases where the plaintiff died prior to the time of settlement from causes unrelated to revision complications.

To be eligible for the settlement, the case must be filed on or before April 15, 2014.  If you or someone you know has suffered injuries believed to have been caused by a Biomet hip implant, the opportunity to take part in this settlement is limited.  Contact a Sommers Schwartz personal injury attorney today to learn how we can help!

Robert B. Sickels

View all posts by
Robert B. Sickels

For more than 30 years, Robert Sickels has successfully represented plaintiffs involved in complex personal injury, medical negligence, and products liability matters.

VIEW BIO

POPULAR

CATEGORIES